Gufic Biosciences receives TGA Australia and ANVISA Brazil approval for Parecoxib 40mg injection
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
Parecoxib Sodium is the first parenteral selective COX-2 inhibitor available for clinical use in pain management
JB Pharma reported 19% decrease in GHG intensity as compared to last year and commenced its journey of Scope 3 emissions
Strides Pharma Science Limited to acquire 100% in Strides Pharma Services Pvt Ltd.
With All India Institute of Ayurveda as a knowledge partner and Sodexo’s culinary expertise, Aarogyum is a well-rounded offering in patient dining solutions
Marking a significant milestone in its commitment to holistic wellness
Biocon Biologics recently acquired the global biosimilars business of its long-term partner Viatris
Dr Jitendra Singh launches API Chapter of AFMC, Pune; inaugurates the first annual conference of API-AFMS Continuing Medical Education (CME) on “Emerging trends in the practice of Medicine”
This indigenously developed enhanced care technology is designed to continuously monitor and detect early signs of deterioration in a patient's condition
This approval has come from the company's finished dosage form manufacturing facility
Subscribe To Our Newsletter & Stay Updated